Flagship explainer

How ImmuCell Corporation makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$27.6M · 100%Cost of revenue$16.2M · 59%Gross profit$11.4M · 41%Operating income$1.6M · 6%Income before tax−$1M · −4%Income tax$11570 · 0%Net income−$1M · −4%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$27.6M100%
Cost of revenue$16.2M59%
$11.4M41%
$1.6M6%
Income before tax−$1M−4%
Income tax$115700%
−$1M−4%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set
Embed this chart

View the full ImmuCell Corporation analysis at Buy Like Buffett